Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 52.34%-48.36K | 22.42%-41.72K | -51.76%-383.29K | 5.84%-68.71K | -216.05%-159.34K | -18.88%-101.46K | -58.98%-53.78K | -750.54%-252.57K | -20.08%-72.97K | 46.31%-50.42K |
| Net income from continuing operations | -266.89%-808.5K | 421.37%712.03K | -54.06%-1.17M | -119.72%-482.02K | -31.66%-243.3K | -31.54%-220.37K | -19.15%-221.56K | -4.73%-757.66K | -112.40%-219.37K | 28.45%-184.8K |
| Operating gains losses | 258.07%14.62K | -674.94%-37.99K | 2,937.40%41.34K | -104.34%-664 | 427.97%44.65K | -172.82%-9.25K | 150.67%6.61K | 101.84%1.36K | 112.97%15.31K | -94.50%-13.61K |
| Depreciation and amortization | -9.48%6.69K | -13.58%6.69K | -5.59%29.15K | -13.58%6.69K | -5.14%7.34K | -6.28%7.39K | 2.90%7.74K | 296.46%30.88K | 46.26%7.74K | 828.81%7.74K |
| Unrealized gains and losses of investment securities | 14,114.64%600K | -29,158.78%-900K | 79,748.17%304.26K | 4,540.56%323.1K | -402.70%-19.98K | 167.14%4.22K | -146.75%-3.08K | 98.36%-382 | -3,045.75%-7.28K | 80.38%6.6K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non cashItems | 31.24%102.24K | 25.86%99.44K | 5.65%303.78K | -7.03%71.49K | 2.03%75.38K | 9.25%77.9K | 4.70%79.01K | 49.29%287.55K | 153.82%76.9K | -70.29%73.88K |
| Change In working capital | -5.31%36.6K | 0.79%78.12K | -43.22%105.44K | -76.37%12.7K | -139.17%-23.41K | 1,232.43%38.65K | 2.51%77.51K | -71.31%185.7K | -81.78%53.73K | 163.75%59.78K |
| -Change in receivables | 65.49%-7.28K | -4.16%17.95K | -104.28%-1.27K | -97.30%690 | -97.19%399 | -38.80%-21.09K | 261.00%18.73K | -89.23%29.76K | 260.25%25.56K | 389.86%14.2K |
| -Change in inventory | --0 | -29.63%57 | -108.95%-2.32K | 143.42%406 | -137.10%-3K | -94.11%185 | -99.48%81 | 3,026.39%25.95K | -974.71%-935 | 1,812.80%8.07K |
| -Change in prepaid assets | ---- | ---- | -147.74%-4.41K | ---4.41K | --0 | --0 | ---- | -61.65%9.23K | --0 | -95.12%3.08K |
| -Change in payables and accrued expense | -26.33%43.87K | 2.41%60.12K | -6.06%113.44K | -45.00%16.01K | -160.47%-20.82K | 971.08%59.55K | 13.59%58.7K | -65.10%120.76K | -90.87%29.11K | 122.59%34.43K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 52.34%-48.36K | 22.42%-41.72K | -51.76%-383.29K | 5.84%-68.71K | -216.05%-159.34K | -18.88%-101.46K | -58.98%-53.78K | -750.54%-252.57K | -14.47%-72.97K | 46.31%-50.42K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -41,203.35%-1.8M | -1.8M | 0 | 0 | -4.36K | 0 | 0 | |||
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---4.36K | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---1.8M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | -41,203.35%-1.8M | ---1.8M | --0 | --0 | ---- | ---4.36K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,381.66%40.4K | -15.23%48.44K | 759.91%2.08M | 4,397.21%1.87M | 108.34%158.5K | -103.91%-3.15K | 68.21%57.14K | 423.06%242.29K | -11.81%41.6K | -21.19%76.08K |
| Net issuance payments of debt | 14.62%-61.6K | -243.65%-8.01K | -99.54%-171.03K | 29.72%-11.52K | -446.39%-87K | -437.49%-72.15K | 112.66%5.58K | -15.66%-85.71K | -154.70%-16.4K | -115.52%-15.92K |
| Cash dividends paid | ---- | --0 | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | 40.17%-3.55K | ---- | ---- | ---- | 0.00%-5.94K | ---5.94K | 0.77%-23.85K | ---- | ---- |
| Net other financing activities | 47.83%102K | 4.35%60K | 587.35%2.25M | 3,145.75%1.88M | 166.85%245.5K | -31.00%69K | -26.28%57.5K | 1,317.64%328K | 150.38%58K | --92K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,381.66%40.4K | -15.23%48.44K | 759.91%2.08M | 4,397.32%1.87M | 108.34%158.5K | -103.91%-3.15K | 68.21%57.14K | 423.06%242.29K | -11.86%41.6K | -21.19%76.08K |
| Net cash flow | ||||||||||
| Beginning cash position | -87.11%14.28K | -92.96%7.56K | -11.99%107.38K | -96.19%5.29K | -94.58%6.13K | -5.99%110.74K | -11.99%107.38K | -22.87%122.02K | 0.13%138.75K | -16.80%113.09K |
| Current changes in cash | 92.39%-7.96K | 99.79%6.72K | -582.08%-99.82K | 107.23%2.27K | -103.25%-835 | -2,121.13%-104.62K | 179.76%3.36K | 59.54%-14.64K | -89.55%-31.37K | 872.45%25.66K |
| End cash Position | 3.10%6.32K | -87.11%14.28K | -92.96%7.56K | -92.96%7.56K | -96.19%5.29K | -94.58%6.13K | -5.99%110.74K | -11.99%107.38K | -11.99%107.38K | 0.13%138.75K |
| Free cash from | 52.34%-48.36K | 22.42%-41.72K | -49.18%-383.29K | 5.84%-68.71K | -216.05%-159.34K | -18.88%-101.46K | -40.84%-53.78K | -761.76%-256.92K | -14.47%-72.97K | 46.31%-50.42K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.